ONGENTYS

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Apr 24, 2020

   6 yr 3 mo ago

2. Today

3. Patent 9550759 expires

   Listed method-of-use patent (U-3870) expiration.

   Jul 26, 2026

   in 1 mo

4. Patent 9550759 expires

   Listed method-of-use patent (U-3871) expiration.

   Jul 26, 2026

   in 1 mo

5. Patent 9550759 expires

   Listed method-of-use patent (U-3872) expiration.

   Jul 26, 2026

   in 1 mo

6. Patent 8907099 expires

   Listed drug substance patent expiration.

   May 12, 2027

   in 11 mo

7. Patent 9745290 expires

   Listed drug product patent expiration.

   Oct 10, 2027

   in 1 yr 4 mo

8. Patent 8168793 expires

   Listed drug substance patent expiration.

   Apr 02, 2029

   in 2 yr 10 mo

9. Patent 8524746 expires

   Listed method-of-use patent (U-3869) expiration.

   Jul 14, 2029

   in 3 yr 1 mo

10. Patent 10071085 expires

    Listed drug product patent expiration.

    Mar 31, 2030

    in 3 yr 10 mo

11. Patent 10583130 expires

    Listed method-of-use patent (U-3869) expiration.

    Mar 31, 2030

    in 3 yr 10 mo

12. Patent 12129247 expires

    Listed method-of-use patent (U-4038) expiration.

    Jan 11, 2032

    in 5 yr 8 mo

13. Patent 9630955 expires

    Listed drug substance patent expiration.

    Dec 12, 2032

    in 6 yr 7 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (11)